HUYABIO INTERNATIONAL ANNOUNCES COMPLETION OF HBI-3000 PHASE 1 TRIAL AND FDA APPROVAL TO PROCEED WITH DOSE ESCALATION IN PHASE 2

/PRNewswire/ -- HUYABIO International, the leader in accelerating global development of China's pharmaceutical innovations, today announced the successful...

Related Keywords

China ,Japan ,United States ,Ireland ,Canada ,South Korea ,American ,Mireille Gillings ,American Heart Association ,University Of Utah ,Drug Association ,Jay Mason ,Atrial Fibrillation ,Huyabio International ,